BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16495496)

  • 1. Characterization of small focal liver lesions using real-time contrast-enhanced sonography: diagnostic performance analysis in 200 patients.
    Xu HX; Liu GJ; Lu MD; Xie XY; Xu ZF; Zheng YL; Liang JY
    J Ultrasound Med; 2006 Mar; 25(3):349-61. PubMed ID: 16495496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
    Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
    Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: receiver operating characteristic analysis.
    Kim SH; Lee JM; Lee JY; Han JK; An SK; Han CJ; Lee KH; Hwang SS; Choi BI
    AJR Am J Roentgenol; 2005 Apr; 184(4):1077-84. PubMed ID: 15788576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of benign from malignant focal splenic lesions using sulfur hexafluoride-filled microbubble contrast-enhanced pulse-inversion sonography.
    Stang A; Keles H; Hentschke S; von Seydewitz CU; Dahlke J; Malzfeldt E; Braumann D
    AJR Am J Roentgenol; 2009 Sep; 193(3):709-21. PubMed ID: 19696284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indeterminate focal liver lesions incidentally discovered at gray-scale US: role of contrast-enhanced sonography.
    Bartolotta TV; Taibbi A; Midiri M; Matranga D; Solbiati L; Lagalla R
    Invest Radiol; 2011 Feb; 46(2):106-15. PubMed ID: 20938345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the echogenicity of focal liver lesions on baseline gray-scale ultrasound interfere with the diagnostic performance of contrast-enhanced ultrasound?
    Liu GJ; Xu HX; Xie XY; Xu ZF; Zheng YL; Liang JY; Lu MD; Moriyasu F
    Eur Radiol; 2009 May; 19(5):1214-22. PubMed ID: 19137313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions.
    von Herbay A; Vogt C; Willers R; Häussinger D
    J Ultrasound Med; 2004 Dec; 23(12):1557-68. PubMed ID: 15557299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20  mm) and subcentimetric (≤ 10  mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial.
    Strobel D; Bernatik T; Blank W; Schuler A; Greis C; Dietrich CF; Seitz K
    Ultraschall Med; 2011 Dec; 32(6):593-7. PubMed ID: 22161556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferumoxides-enhanced double-echo T2-weighted MR imaging in differentiating metastases from nonsolid benign lesions of the liver.
    Arbab AS; Ichikawa T; Sou H; Araki T; Nakajima H; Ishigame K; Yoshikawa T; Kumagai H
    Radiology; 2002 Oct; 225(1):151-8. PubMed ID: 12354999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Undetermined focal liver lesions on gray-scale ultrasound in patients with fatty liver: characterization with contrast-enhanced ultrasound.
    Wang ZL; Tang J; Weskott HP; Li JL; Wang W; Luo YK; An LC; Xu JH
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1511-9. PubMed ID: 18713302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of hypoechoic focal hepatic lesions in patients with fatty liver: diagnostic performance and confidence of contrast-enhanced ultrasound.
    Bartolotta TV; Taibbi A; Galia M; Runza G; Matranga D; Midiri M; Lagalla R
    Eur Radiol; 2007 Mar; 17(3):650-61. PubMed ID: 17180328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced sonography in the diagnosis of small hepatocellular carcinoma < or =2 cm.
    Xu HX; Xie XY; Lu MD; Liu GJ; Xu ZF; Zheng YL; Liang JY; Chen LD
    J Clin Ultrasound; 2008 Jun; 36(5):257-66. PubMed ID: 18088056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidentally detected splenic lesions in ultrasound: does contrast-enhanced ultrasonography improve the differentiation of benign hemangioma/hamartoma from malignant lesions?
    Stang A; Keles H; Hentschke S; von Seydewitz CU; Dahlke J; Habermann C; Wessling J
    Ultraschall Med; 2011 Dec; 32(6):582-92. PubMed ID: 22161555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal characteristics of focal liver lesions on double echo T2-weighted conventional spin echo MRI: observer performance versus quantitative measurements of T2 relaxation times.
    Fenlon HM; Tello R; deCarvalho VL; Yucel EK
    J Comput Assist Tomogr; 2000; 24(2):204-11. PubMed ID: 10752879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients.
    von Herbay A; Westendorff J; Gregor M
    J Clin Ultrasound; 2010 Jan; 38(1):1-9. PubMed ID: 19790253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal liver lesions: detection and characterization at double-contrast liver MR Imaging with ferucarbotran and gadobutrol versus single-contrast liver MR imaging.
    Heilmaier C; Lutz AM; Bolog N; Weishaupt D; Seifert B; Willmann JK
    Radiology; 2009 Dec; 253(3):724-33. PubMed ID: 19789232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of contrast-enhanced ultrasound for complex cystic focal liver lesions: blinded reader study.
    Lin MX; Xu HX; Lu MD; Xie XY; Chen LD; Xu ZF; Liu GJ; Xie XH; Liang JY; Wang Z
    Eur Radiol; 2009 Feb; 19(2):358-69. PubMed ID: 18795298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver.
    von Herbay A; Vogt C; Häussinger D
    AJR Am J Roentgenol; 2002 Nov; 179(5):1273-9. PubMed ID: 12388513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent.
    Xu HX; Liu GJ; Lu MD; Xie XY; Xu ZF; Zheng YL; Liang JY
    J Clin Ultrasound; 2006; 34(6):261-72. PubMed ID: 16788957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.